Dalteparin (Fragmin)

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center, Pfizer

Conditions

Deep Vein ThrombosisNeoplasmsVenous Thromboembolism

Phase 2

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

TerminatedNCT00041782

M.D. Anderson Cancer CenterDeep Vein Thrombosis, Neoplasms

Start: 2000-10-31End: 2005-01-31Updated: 2018-10-31

Phase 4

Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients

TerminatedNCT00445328

PfizerVenous Thromboembolism

Start: 2007-06-30End: 2008-07-31Updated: 2009-10-15